×

Method to determine outcome for patients with prostatic disease

  • US 20030235816A1
  • Filed: 03/14/2003
  • Published: 12/25/2003
  • Est. Priority Date: 03/14/2002
  • Status: Abandoned Application
First Claim
Patent Images

1. A method to determine the risk of progression of a prostate cancer patient after therapy, comprising:

  • a) detecting or determining the amount or level of VEGF, UPAR, UPA, or sVCAM in a blood sample obtained from a patient prior to therapy for clinically localized prostate cancer; and

    b) correlating the amount or level of VEGF, UPAR, UPA, or sVCAM with the risk of progression.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×